Conestoga Capital Advisors, LLC Vericel Corp Transaction History
Conestoga Capital Advisors, LLC
- $6.22 Billion
- Q3 2025
A detailed history of Conestoga Capital Advisors, LLC transactions in Vericel Corp stock. As of the latest transaction made, Conestoga Capital Advisors, LLC holds 2,175,284 shares of VCEL stock, worth $75.1 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
2,175,284
Previous 2,463,590
11.7%
Holding current value
$75.1 Million
Previous $105 Million
34.69%
% of portfolio
1.1%
Previous 1.56%
Shares
25 transactions
Others Institutions Holding VCEL
# of Institutions
293Shares Held
53.8MCall Options Held
35.6KPut Options Held
7.7K-
Black Rock Inc. New York, NY8.06MShares$278 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$123 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.81MShares$97.1 Million3.59% of portfolio
-
State Street Corp Boston, MA2.44MShares$84.1 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.99MShares$68.8 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.63B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...